Abgenix Inc (1052837) SEC Filing 8-K Material Event for the period ending Wednesday, December 14, 2005

Abgenix Inc

CIK: 1052837

View differences made from one to another to evaluate Abgenix Inc's financial trajectory

Compare SEC Filings Year-over-Year (YoY) and Quarter-over-Quarter (QoQ)
Sample 10-K Year-over-Year (YoY) Comparison

Compare this 8-K Corporate News to its predecessor by reading our highlights to see what text and tables were  removed  ,   added    and   changed   by Abgenix Inc.


Assess how Abgenix Inc's management team is paid from their Annual Proxy

Definitive Proxy Statement (Form DEF 14A)
Screenshot example of actual Proxy Statement

Abgenix Inc's Definitive Proxy Statement (Form DEF 14A) filed after their 2005 10-K Annual Report includes:

  • Voting Procedures
  • Board Members
  • Executive Team
  • Salaries, Bonuses, Perks
  • Peers / Competitors


SEC Filing Tools
CIK: 1052837
Form Type: 8-K Corporate News
Accession Number: 0001104659-05-060879
Submitted to the SEC: Wed Dec 14 2005 9:35:55 PM EST
Accepted by the SEC: Thu Dec 15 2005
Period: Wednesday, December 14, 2005
Industry: Biological Products No Disgnostic Substances
  1. Financial Exhibit
  2. New Agreement
  3. Regulated Disclosure

External Resources:

Bookmark the Permalink: